Literature DB >> 20562255

Chronic ambulatory intracardiac pressures and future heart failure events.

Lynne Warner Stevenson1, Michael Zile, Tom D Bennett, Fred J Kueffer, Mariell L Jessup, Philip Adamson, William T Abraham, Ven Manda, Robert C Bourge.   

Abstract

BACKGROUND: Intracardiac pressures in heart failure (HF) have been measured in patients while supine in the hospital but change at home with posture and activity. The optimal level of chronic ambulatory pressure is unknown. This analysis compared chronic intracardiac pressures to later HF events and sought a threshold above which higher pressures conferred worse outcomes. METHODS AND
RESULTS: Median pressures were measured every 24 hours from continuous 8-minute segments for 6 months after implantation of hemodynamic monitors in 261 patients with New York Heart Association class III-IV HF in the Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure Study. Baseline and chronic daily medians of estimated pulmonary artery diastolic, right ventricular systolic, and right ventricular end-diastolic pressures were compared with HF event rate. The group median for chronic 24-hour estimated pulmonary artery diastolic pressure was 28 mm Hg (excluding 7 days before and after events). Despite weight-guided management, events occurred in 100 of 261 (38%) patients. Event risk increased progressively with higher chronic 24-hour estimated pulmonary artery diastolic pressure, from 20% at 18 mm Hg to 34% at 25 mm Hg and 56% at 30 mm Hg, with similar relations for right ventricular pressures. Among patients with baseline day median estimated pulmonary artery diastolic pressures of ≥25 mm Hg, event risk was 1.10/6 mo when they remained chronically ≥25 mm Hg, but risk fell to 0.47 when 24-hour pressures declined to <25 mm Hg for more than half of the days.
CONCLUSIONS: Despite current management, many patients with advanced HF live on a plateau of high filling pressures from which later events occur. This risk is progressively higher with higher chronic ambulatory pressures. It is not known whether more targeted intervention could maintain lower chronic ambulatory pressures and better outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20562255     DOI: 10.1161/CIRCHEARTFAILURE.109.923300

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  32 in total

1.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

Review 2.  Remote hemodynamic monitoring for ambulatory left ventricular assist device patients.

Authors:  Brent C Lampert; Sitaramesh Emani
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 3.  Remote Monitoring to Reduce Heart Failure Readmissions.

Authors:  Sitaramesh Emani
Journal:  Curr Heart Fail Rep       Date:  2017-02

Review 4.  Loop diuretics in heart failure.

Authors:  G Michael Felker
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 5.  Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents.

Authors:  Marco Metra; Luca Bettari; Valentina Carubelli; Silvia Bugatti; Alessandra Dei Cas; Francesca Del Magro; Valentina Lazzarini; Carlo Lombardi; Livio Dei Cas
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

Review 6.  [Telemonitoring and pulmonary artery pressure-guided treatment of heart failure].

Authors:  C E Angermann; S Rosenkranz
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

Review 7.  Noncardiac comorbidities and acute heart failure patients.

Authors:  Robert J Mentz; G Michael Felker
Journal:  Heart Fail Clin       Date:  2013-05-23       Impact factor: 3.179

Review 8.  Cardiac Rehabilitation to Optimize Medication Regimens in Heart Failure.

Authors:  Parag Goyal; Eiran Z Gorodeski; Zachary A Marcum; Daniel E Forman
Journal:  Clin Geriatr Med       Date:  2019-06-21       Impact factor: 3.076

Review 9.  Implantable devices to monitor patients with heart failure.

Authors:  Nikolaos Karamichalakis; John Parissis; George Bakosis; Vasiliki Bistola; Ignatios Ikonomidis; Antonios Sideris; Gerasimos Filippatos
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

Review 10.  Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

Authors:  Michael R Zile; Catalin F Baicu
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.